Latest in Cardiology from ACC.org

• HI-PEITHO and the Evolution of Reperfusion Strategies in Pulmonary Embolism
  Management of intermediate-risk pulmonary embolism (PE) remains one of the most challenging areas in venous thromboembolism care. These patients are hemodynamically stable but have right ventricular (RV) dysfunction and myocardial injury, placing them at increased risk of clinical deterioration.
• Eagle’s Eye View: Top Trials from ESC 26
  In this week’s View, Dr. Eagle looks at some of the important trials presented at this year’s European Society of Cardiology (ESC) Congress.
• ACCEL Lite: Impacts Of The FUND-HF Trial
  In this interview, Alison L. Bailey, MD, FACC and Ambarish Pandey, MD, MS examine the effect of financial support on quality of life and medication adherence among low-income patients following hospitalization for heart failure.
• ACC/AHA Scientific Statement Focuses on CV Risk Evaluation, Management For Tactical Athletes
  A new ACC/AHA Scientific Statement provides the first comprehensive framework for cardiovascular evaluation and management of tactical athletes, including the more than 4 million Americans currently serving as military personnel, firefighters, law enforcement officers, EMS professionals, pilots and astronauts.
• Eagle’s Eye View: M-TEER Improves MR and LV Dysfunction
  In this week’s View, Dr. Eagle evaluates how sacubitril/valsartan promotes cardiac remodeling, but not functional capacity, in nonobstructive hypertrophic cardiomyopathy.